{"name":"Remedy Pharmaceuticals, Inc.","slug":"remedy-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-06","type":"deal","source":"Newswise","summary":"New Research Challenges FTC’s Pharmaceutical Merger Remedy Policy | Newswise - Newswise","headline":"New Research Challenges FTC’s Pharmaceutical Merger Remedy Policy | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNTNXaHVZam8yQVZ4Tnd4UXN1TEs4WUpMVlY3MllVVW9CN1VSRXBSdWFIcUxfX3lJMmpJLVJEblR5QzQ2enVZS05EQWJrU1lGMkp0N1RNa2pRWnMya0FPYzhuQWgzUGs4TEFaQjF2cDVuV3A4UE5kUzUtRF9yOFVQUmhPNDZQRVc1Vy1FS1hGNTY0cUFpMGdPUGJVaUF0ZjM4aENoZ2s4YThSZkxKaWNmTG14ZnZDRkxrSDRnVUlWSdIBxAFBVV95cUxQTVVXSnpqNnFZTGJVVmpLWW05eXdZOTZuaGFteFBtVzR1QjlwUGdCcXBtVTdNSzVvODdZNEtobmhCSmNUVllSbjVzU00ya0JDMTJ3MUpGZEs1T1hINVozLVk4TzBHbl9GWXBoU2xWZ0tOaFBRcVRJZTU1MHppalh1XzZTd0ZuNER0eFVnMkpHTW1wVV9iWWhRYzNEMjVGRkZqOEhmZXBqVkpJZkRIdERldTBRRHd2SE1wUm5yemdRQXdNZ0tL?oc=5","date":"2026-01-27","type":"pipeline","source":"Express Pharma","summary":"Venus Remedies receives second PLI incentive disbursement, reinforcing manufacturing strength - Express Pharma","headline":"Venus Remedies receives second PLI incentive disbursement, reinforcing manufacturing strength","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPcnZ5cjdUb295ZlcwUmQzbVpYS0tkd2o1d1IwZXMzaXlWLWtOZzFuQU1YdTVSMEhPTndvREJJYVBQQTk3TXk4eGlfOHBpYUx1M2NYRmV5M0Myb2VCd2dldWY4eDZtTzN2RDZMLU5sTWtVYnVIQ3Z5ZktnZFUwTVhGRHpFdjFzZU1lMm5tb3FoZXoweFJNcHNCYS1SWlVrWk00SXg4UTFfYUpXclJGdzhFRE5GN0xlZlR3b1RqY1lPdUQxckEyYVBfTF9Wbw?oc=5","date":"2025-11-10","type":"earnings","source":"scanx.trade","summary":"Venus Remedies Reports 40.5% Revenue Growth in Q2 FY26 Despite Subsidiary Challenges - scanx.trade","headline":"Venus Remedies Reports 40.5% Revenue Growth in Q2 FY26 Despite Subsidiary Challenges","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-09","type":"pipeline","source":"The Economic Times","summary":"Venus Remedies gets new market authorisations for drugs in Vietnam - The Economic Times","headline":"Venus Remedies gets new market authorisations for drugs in Vietnam","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRlZ6UjJ5elFPTUdZYjJoTUh3U3VtbXE2SmFSQzhsSzNCY2kzalVOWXdQRHctc2RpTFlRQnBTQ1hrclVsT0J3ZVBrQkNJQ09xQ1BIU1cyQndUOXF6SGtrMENIanYxcnBwWGloS3NDWGRzb2xZcDlFdHBFUjNLNVlLdGF1dUdNNXZfLWczZ0pQN0VjNmZWQzJwb1MyZW91WGtlOW5HUVRaYVprMWhfV0pfdFFoNm1lc2FVbzVmUGZQRzBtOHYzSkk2eFB30gHPAUFVX3lxTFBIUmlUNnVucmM0R1hrbWV3V1Z0RkpnTHJqVDRLSDN5QTNkQ29JbnNZVHl3dGdLdk5MZFNBcjNjbDUzUGp1SG5ZLVRIQ1hNNGgwVmhhazVfVXZDQmJWQ3JGZUhHbGxQWURoZnJhZ3dfM3FaeXFFcFZtRXZIcE9JX2p2emxGX0tIY0lBMW5CVEctdUd6ckxpeXliTVVzb1ZvbUVzeUNQNEswc2Z3VldNU3liV2F6QmpTQ205SVU0TkhValVXSS1zOUpicEZJLU1aTQ?oc=5","date":"2025-08-13","type":"regulatory","source":"medicaldialogues.in","summary":"Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - medicaldialogues.in","headline":"Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-17","type":"deal","source":"Business Standard","summary":"CORONA Remedies acquires 7 pharma brands from Bayer India, plans expansion - Business Standard","headline":"CORONA Remedies acquires 7 pharma brands from Bayer India, plans expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQNk5RMEFMUjdiLUlySFMyeUhmMEV5Tjc4R3VpTWtYcWFjTUUxVVBCbEpMVU96em9WVVlsa0txRUVDTlRVV2N3RVFidzZCZ1oyRXdoYlAwdFNFY2Qya3ZudmlrRE4yekRPXzhQY3RRdjZMcVUtVDVPay1UOFdzSF9ocFI1dThqanBFdVBOYkptbmc1VlJG?oc=5","date":"2025-05-14","type":"regulatory","source":"Frontiers","summary":"From ‘traditional’ remedies to ‘modern’ supplements: a systematic review and meta-analysis of pharmaceutical adulteration in weight-loss natural products - Frontiers","headline":"From ‘traditional’ remedies to ‘modern’ supplements: a systematic review and meta-analysis of pharmaceutical adulteratio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOUU1na3phRkRQWE5wUWJPU3lMT1UwZzNKQ2cwNE1yOGI0TWJiU01FTzVGSG5oX0lOU0ZuWXdEYWNvdTF4cHJBUUlMQjBfR3RROXViTHpUTExVdTNTNzZXWU9KS1RLM3ZONHRoVk85T0JPbFJmeHhUN3hfWWVIRjhDU3A0UUU4SnBtWnZuNERnaW0wcm5q?oc=5","date":"2025-05-13","type":"pipeline","source":"The Pharma Letter","summary":"Remedy’s $18 million round takes total funding to $55 million - The Pharma Letter","headline":"Remedy’s $18 million round takes total funding to $55 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxNc1VPNE1XYU1yVk9kR2lkRnF6T2VhUDJYR19RLUtvU2UxY1BtcVpCRm1ybXVKS2VJTVh0S0o4ZU8yV1h2STFvX204c1hqTG40Tms3OVZQMVVQZlhTblRYSnNudEdCZ3ljcUcxd3dUSEJDYkE2cVpfNThGZ3AyNW5SREMtOU44dmgyMmRobFZhblNOTjVsRWdNSVFMR0VvZFUwWVgtMDhoRkFnSnk2ZENBQWN4YXI3TUNtVUZLQXhLRjRlZkhtdklQUVUtUmJIVUhRNmQ3X2cxT1JaTzFySmtlemwtWVNNRTllNncxeFUwZWtLT1JVd2dTN1ZOSGFKXzc5aW42UlZHUzNkUTV5QmpRN19PUjlOdzJIZ3B5NQ?oc=5","date":"2025-05-13","type":"pipeline","source":"GlobeNewswire","summary":"Remedy Plan Therapeutics Raises $18 Million Financing to - GlobeNewswire","headline":"Remedy Plan Therapeutics Raises $18 Million Financing to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOYUt3cEZjSjV5UFRZbi1ZdzdoRlFUekRwSjRrRWVEclVQVkpTSkt1Q09lWU81Ynp4Yk1XTTY0R3BhOXBwd3dfRDdZelN6Xzl6cDFVQ2g1U0pub3NPVm0xVlpHblFQV25Fck9JOEUyZkl3ZzJMNzUwZFE2SW93WUg2V2xLa2JISndMYnNnaldhU1l0bXpBbmR3UzA5Q2JzUGJyaUFvMmxibUYxY3p3QlBPb2VQanZTM09DZUNzRk12WVJxNmh6NDd5Umt2b1RFM2MyOWJ5ejJ4OHNWcVZac2ZaTGN3QU9paG5iSkNHX2FXMTFoT3VpMU5meVRwSzZYZ2ExVENiRVZJSDdXMEx4Z0dMaUhVd3k?oc=5","date":"2025-02-19","type":"trial","source":"BioSpace","summary":"International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Improvements in Stroke Outcomes - BioSpace","headline":"International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Imp","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2024-05-29","type":"trial","source":"prnewswire.com","summary":"Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back From Biogen; Announces Clinically Meaningful and Statistically Significant Results From Pre-specified Subgroup and Post Hoc Analyses of Pha","headline":"Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back From Biogen; Announces Clinically Meaningful and Statistica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPcTM4R3JiWmhSeGxEZkZHNDdfTEJaMFduMGtPc24xQnAyRDBYamtlNi1rekRXX3l3NDNPQUR1TTE4TTEtQUoyb1hkNmZpSmliaGVpQjgza0tLQlBCQWtSd1hnWEltZUU4WXRQeVIySTVrQmVDWHRKX2Z5YUdWSW5FeFA3MTZBLWFhSXUwYUg5bC1hdTBOcG5wSlBwYWlKdExHWFBYMGNqS09URzJOdE5vVUpyUk4yLWNy?oc=5","date":"2017-05-15","type":"deal","source":"Biogen","summary":"Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke - Biogen","headline":"Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}